Joseph Cappello - VP, Pharmaceutical Development at GENELUX Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
VP, Pharmaceutical Development
Stock Symbol
GNLX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Joseph Cappello - trading volume in the past year for GENELUX Corp

Holdings reported by Joseph Cappello for GENELUX Corp

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 5,735 $81.3 K $14.18 Aug 18, 2023 Direct
Stock Option (right to buy) 65,000 Sep 11, 2023 Direct Common Stock

Transactions reported by Joseph Cappello for GENELUX Corp

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership